Rechercher | Socid Friendly

Rishika Datta Ajout d’un nouvel article Health
2026-03-27 07:53:13

Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry Adoption
According to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of biologics over conventional treatments, and...

0 Commentaires 0 Parts 2261 Vue

Connectez-vous pour aimer, partager et commenter!
Deepak Patle Ajout d’un nouvel article Autre
2026-03-16 10:27:08

Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape, Differentiation Strategies and Forecast to 2033
Cancer Immunotherapy Drug Discovery Outsourcing Industry Insights: Straits Research recently introduced the latest update on the Cancer Immunotherapy Drug Discovery Outsourcing Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and...

0 Commentaires 0 Parts 2314 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-04-18 10:04:55

Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034
According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...

0 Commentaires 0 Parts 2274 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra

Ajout d’un nouvel article Autre
2026-07-10 11:55:24

Global Durvalumab Market Growing at 10.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Durvalumab Market was valued at USD 1.85 billion in 2025 and is projected to grow from USD 2.12 billion in 2026 to USD 4.76 billion by 2034, exhibiting a robust CAGR of 10.6% during the forecast period. Growth is driven by increasing cancer prevalence, advancements in immuno-oncology research, and rising investments in targeted...

0 Commentaires 0 Parts 849 Vue

Connectez-vous pour aimer, partager et commenter!